Liver International: Vol 40, No 11

I consent to Wiley Online Library’s Terms of Use and processing of my personal data as disclosed in Wiley’s Privacy Policy.I consent to my personal information being transferred outside of the People’s Republic of China as laid out in Wiley’s Privacy Policy.*(Optional) I consent to special offers, newsletter & promotions from Wiley. See Privacy Policy for more details.

Tools

Submit an article

Journal Metrics

Subscribe to this journal

Liver International

Journal list menu

Tools

Follow journal

Liver International: Volume 40, Issue 11

Download PDFs

ISSUE INFORMATION

Issue Information

REVIEWS & META-ANALYSES

Pituitary adenylate cyclase-activating peptide: Potential roles in the pathophysiology and complications of cirrhosis

Primary biliary cholangitis management: controversies, perspectives and daily practice implications from an expert panel

Normal liver stiffness and influencing factors in healthy children: An individual participant data meta-analysis

LncRNA NEAT1: Shedding light on mechanisms and opportunities in liver diseases

EDITORS' PERSPECTIVE

Sarcopenia in chronic liver disease: easy to diagnose but hard to treat

LIVER DISEASE AND PUBLIC HEALTH

Health related quality of life in chronic liver diseases

Long-term clinical benefits of Sofosbuvir-based direct antiviral regimens for patients with chronic hepatitis C in Central and West Africa

VIRAL HEPATITIS

Running out of bullets: The challenging management of acute hepatitis and SARS-COV-2 from the SMatteo COvid19 Registry (SMACORE)

Treatment outcomes in hepatitis C virus genotype 1a infected patients with and without baseline NS5A resistance-associated substitutions

Distinct T-cell receptor profiles associated with hepatitis B e antigen seroconversion during entecavir treatment

Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China: A single-arm, open-label, phase 3 trial

METABOLIC & TOXIC LIVER DISEASES

Early life famine exposure, adulthood obesity patterns and the risk of nonalcoholic fatty liver disease

Interaction between CHOP and FoxO6 promotes hepatic lipid accumulation

Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver disease

Steatosis as main determinant of portal hypertension through a restriction of hepatic sinusoidal area in a dietary rat nash model

GUT-LIVER AXIS, IMMUNOLOGY, IMMUNE MEDIATED AND CHOLESTATIC DISEASES

Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis

The Simple Cholestatic Complaints Score is a valid and quick patient-reported outcome measure in primary sclerosing cholangitis

Bilirubin and bile acids in osteocytes and bone tissue. Potential role in the cholestatic-induced osteoporosis

GENETICS AND RARE LIVER DISEASES

mtDNA depletion-like syndrome in Wilson disease

ABCB11 deficiency presenting as transient neonatal cholestasis: Correlation with genotypes and BSEP expression

CIRRHOSIS, LIVER FAILURE AND TRANSPLANTATION

MRI-defined sarcopenia predicts mortality in patients with chronic liver disease

Impaired myosin isoform shift and calcium transients contribute to cellular pathogenesis of rat cirrhotic cardiomyopathy

Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosis

LIVER CANCER

GES: A validated simple score to predict the risk of HCC in patients with HCV-GT4-associated advanced liver fibrosis after oral antivirals

TP53 R249S mutation detected in circulating tumour DNA is associated with Prognosis of hepatocellular carcinoma patients with or without hepatectomy

Proton pump inhibitors and odds of cholangiocarcinoma: A retrospective case-control study

LIVER INTERNATIONAL IMAGES

Polyarteritis nodosa with intra-hepatic arterial haemorrhage

EXPERIMENTAL HEPATOLOGY

Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative

LETTERS TO THE EDITOR

Response to letter to the editor

A letter of solidarity during the COVID-19 pandemic

Discontinuation rate of azathioprine

Concordance between MAFLD and NAFLD diagnostic criteria in ‘real-world’ data

Authors’ response to ‘Concordance of MAFLD and NAFLD diagnostic criteria in "real-world" data’

Sign up for email alerts

Tools

More from this journal